Halaman 4 - Kanker prostat Dokter Terbaik - TOP-148 dokter

Associate Professor Dr. Yusuf Acikgoz membawa pengalaman uji klinis yang luas dalam pengobatan kanker prostat di Rumah Sakit Universitas Lokman Hekim Ankara.

• Berpartisipasi dalam uji klinis Fase III seperti CheckMate-649 dan Fortitude-101
• Menempuh pelatihan di Ohio State University – pemimpin dalam penelitian onkologi
• Tersertifikasi dalam Praktik Klinis yang Baik (GCP) dan pelaksanaan penelitian yang bertanggung jawab
• Menjadi anggota komunitas American Society of Clinical Oncology (ASCO)

Associate Professor Tahsin Ozatli berspesialisasi dalam mengobati kanker prostat di Rumah Sakit Liv Universitas Istinye Bahcesehir.

• Spesialis Penyakit Dalam dengan pengalaman bertahun-tahun
• Mantan dokter di Klinik Onkologi Ankara
• Menyelesaikan pendidikan di Fakultas Kedokteran Universitas Selcuk
• Diangkat menjadi Associate Professor pada tahun 2016

Profesor Cemil Bilir menggabungkan keahlian akademik dalam onkologi medis dengan pelatihan internasional – termasuk penelitian di Northeastern University di Boston.

• Spesialisasi dalam onkologi medis dengan pengalaman 13+ tahun
• Anggota ASCO, ESMO, dan TTOD – organisasi onkologi terkemuka
• Profesor aktif di Fakultas Kedokteran Universitas Sakarya
• Terlatih di Cleveland Clinic untuk reumatologi dan gastroenterologi

Prof. Madya dr. Nail Paksoy berspesialisasi dalam pengobatan kanker prostat di Rumah Sakit Medipol Bahçelievler, dengan Sertifikasi Dewan ESMO dalam Onkologi Medis.

• Menyelesaikan spesialisasi onkologi medis di Institut Onkologi Universitas Istanbul
• Menerbitkan penelitian tentang beban tumor berbasis PSMA pada kanker prostat
• Berpartisipasi dalam uji klinis internasional untuk pengobatan kanker stadium lanjut
• Bersertifikat Dewan ESMO dalam Onkologi Medis sejak 2022

Profesor Gul Alco berspesialisasi dalam onkologi radiasi untuk kanker prostat di Universitas Medipol Istanbul.

• Pengalaman lebih dari 20 tahun di bidang onkologi radiasi
• Lektor Kepala dan kemudian Profesor di Universitas Demiroglu Bilim
• Menyelesaikan residensi di Universitas Kadir Has
• Bekerja di Rumah Sakit Distrik Medipol Acibadem

Dr. Ozden memiliki lebih dari 20 tahun pengalaman medis, dengan spesialisasi dalam pengobatan kanker prostat di Rumah Sakit VM Medical Park Pendik.

• Lulus dari Fakultas Kedokteran Cerrahpaşa yang bergengsi di Universitas Istanbul
• Menyelesaikan subspesialisasi onkologi medis di Universitas Kocaeli
• Pengalaman luas dalam penyakit dalam sebelum fokus pada onkologi

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Alemdar membawa lebih dari 15 tahun pengalaman medis, dengan spesialisasi dalam perawatan kanker prostat di Kompleks Rumah Sakit Medical Park Antalya.

• Tersertifikasi dalam Onkologi Medis dengan pelatihan khusus di Universitas Akdeniz
• Pengalaman luas di berbagai rumah sakit universitas dan pemerintah di Turki
• Ahli dalam protokol pengobatan kanker prostat terbaru
• Berfokus pada rencana perawatan pribadi yang disesuaikan dengan kebutuhan setiap pasien

30+ tahun di bidang imunologi dengan fokus pada viroterapi – Dr. Jaunalksne memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins.

• Spesialisasi dalam perawatan viroterapi mutakhir
• Memimpin Pusat Imunologi Klinis di rumah sakit universitas terkemuka
• Lulus dari Institut Medis Riga dengan magang di Penyakit Dalam

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Dr. Son Dong Wan, MD, PhD, is the Chief of Urology at Naeun Hospital. He specializes in urologic oncology, urinary incontinence, sexual dysfunction, and laser prostate surgery. He performs robotic and laparoscopic surgery for cancers of the prostate, bladder, ureter, and kidney. He also treats ureteropelvic junction (UPJ) obstruction.

He earned his PhD from Pusan National University. He completed his internship and residency at Pusan National University Hospital. He is a former Chief at Wallace Memorial Baptist Hospital. He served as a Professor at the Catholic University College of Medicine. He was a Clinical Fellow at Seoul National University Bundang Hospital. He was a Visiting Professor at the University of California, San Diego (UCSD). He completed training in urinary incontinence surgery at the University of Liège.

Awards include the Excellent Paper Award (2007) and the Academic Achievement Award (2014) from the Korean Continence Society. He also received the Best Poster Award from the European Association of Urology (2013).